Narcotic-Related Disorders
7
2
4
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Maternal Brain Imaging in Opioid Use Disorder
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
Safe Prescription of Opioids in Primary Care
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
GLP-1R Agonist Treatment for Opioid Use Disorder
Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder